Literature DB >> 23998425

Differential gene hypermethylation in genital lichen sclerosus and cancer: a comparative study.

David Guerrero-Setas1, Noemí Pérez-Janices, Amaya Ojer, Laura Blanco-Fernandez, Carmen Guarch-Troyas, Rosa Guarch.   

Abstract

AIMS: Lichen sclerosus (LS) is a chronic inflammatory disease of the genital skin of unknown aetiology. The role of LS in penile squamous cell carcinogenesis is not well characterized. HPV has been implicated in both, as have epigenetic changes. The presence of HPV and hypermethylation of the MGMT, p16, RASSF1, RASSF2, TSLC1 and TSP1 genes were studied in penile LS; MGMT, RASSF2 and TSLC1 hypermethylation in penile cancer and TSLC1 hypermethylation in vulvar LS and cancer extends previous results reported by our group. METHODS AND
RESULTS: Thirty-seven HPV genotypes and hypermethylation were evaluated by PCR/reverse-line-blot and methylation-specific PCR respectively, in 27 preputial LS, 24 penile SCC, 30 vulvar SCC, 21 vulvar LS and 22 normal skin cases. HPV66 was present in 3.7% of penile LS cases, and p16 and RASSF2 hypermethylation were more frequent in penile cancer than in penile LS. p16, RASSF1, RASSF2 and TSP1 hypermethylation were similar in penile and vulvar LS.
CONCLUSIONS: Gene hypermethylation is a common event in penile LS, and occurs approximately as frequently as in vulvar LS. Certain genes can be hypermethylated as an early or late event in LS or cancer, respectively. This suggests a possible sequential role for these alterations in the transition from benign to malignant lesions.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  human papillomavirus; hypermethylation; lichen sclerosus; penile cancer; vulvar cancer

Mesh:

Year:  2013        PMID: 23998425     DOI: 10.1111/his.12204

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.

Authors:  E Martín-Sánchez; E Pernaut-Leza; S Mendaza; A Cordoba; F Vicente-Garcia; I Monreal-Santesteban; J Pérez Vizcaino; M J Díaz De Cerio; N Perez-Janices; I Blanco-Luquin; D Escors; A Ulazia-Garmendia; D Guerrero-Setas
Journal:  Virchows Arch       Date:  2016-04-21       Impact factor: 4.064

2.  EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas.

Authors:  N Perez-Janices; I Blanco-Luquin; M T Tuñón; E Barba-Ramos; B Ibáñez; I Zazpe-Cenoz; M Martinez-Aguillo; B Hernandez; E Martínez-Lopez; A F Fernández; M R Mercado; T Cabada; D Escors; D Megias; D Guerrero-Setas
Journal:  Oncotarget       Date:  2015-01-01

3.  DNA methylation markers for cancer risk prediction of vulvar intraepithelial neoplasia.

Authors:  Nikki B Thuijs; Johannes Berkhof; Müjde Özer; Sylvia Duin; Annina P van Splunter; Barbara C Snoek; Daniëlle A M Heideman; Marc van Beurden; Renske D M Steenbergen; Maaike C G Bleeker
Journal:  Int J Cancer       Date:  2021-01-10       Impact factor: 7.396

4.  Diversity of patient profile, urethral stricture, and other disease manifestations in a cohort of adult men with lichen sclerosus.

Authors:  Peter Stanford Kirk; Yooni Yi; Miriam Hadj-Moussa; Bahaa Sami Malaeb
Journal:  Investig Clin Urol       Date:  2016-05-10

5.  Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.

Authors:  Noemi Perez-Janices; Idoia Blanco-Luquin; Natalia Torrea; Therese Liechtenstein; David Escors; Alicia Cordoba; Francisco Vicente-Garcia; Isabel Jauregui; Susana De La Cruz; José Juan Illarramendi; Valle Coca; Maria Berdasco; Grazyna Kochan; Berta Ibañez; José Miguel Lera; David Guerrero-Setas
Journal:  Oncotarget       Date:  2015-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.